DHDaniel Hausermann

Daniel Hausermann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Hausermann has a total of 121 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhanced Efficacy of Multiport Synchrotron Microbeam Radiation Therapy for Brain Tumors in Rats

    by Laura Eling, Liam Day, Micah Barnes, Matthew Cameron, Michael De Veer, My-Linh Tempo, Helen Forrester, Mitzi Klein, Daniel Hausermann, Jean A. Laissue, et al.

    Microbeam Radiation Therapy (MRT) is a drastically novel approach of radiosurgery, challenging the understanding of how normal tissues respond to radiation therapy, where X-rays generated by a synchrotron light source are collimated into wafers of high-dose (hundreds of Gray), thin (50 µm) parallel microbeams. Recent work showed that MRT dose prescription must consider a dual approach: separating normal tissue dose constraints tied to the valley dose prescription and anti-tumor effects, depending on the prescribed number of ports. Here, we consolidate this assumption by increasing the number of MRT incidences to irradiate 9L-bearing rats with a cumulated valley dose of 10 Gy. 9L-bearing rats were irradiated by eight ports of conventional Broad Beam (BB) or MRT. Animals were followed up clinically by MR imaging, histopathology and survival analysis. MRI follow-up revealed that MRT significantly amplified antitumor effect and tumor tissue damage while improving the clinical score of animals. Ten Gy, delivered by either BB or MRT, increased median survival time to 15 and 39.5 days after irradiation, respectively. Neither complete ablation of brain tumors nor long-term survival was achieved, but multiport MRT (eight ports) showed an outstanding dose equivalence factor (×2.9), which needs to be tested in a clinical environment.

  • Open Access

    Diagnostic performance of phase-contrast computed tomography versus digital mammography: A pilot study

    by S. Tavakoli Taba, S.L. Hillis, A. Huda, D. Lockie, J. Fox, B. Kumar, M. Rickard, D. Hausermann, M.E. Suleiman, Z. Gandomkar, et al.

  • Open Access

    PEERing into the Future: Benchmarking the ANSTO Australian Synchrotron’s Very-High-Energy Electron Linac for Ultra-High Dose-Rate, In Vivo FLASH Radiotherapy Research

    by James Cayley, Elette Engels, Tessa Charles, Kiarn Roughley, Marie Wegner, Sarah Koschny, Kirsty Brunt, Matthew Cameron, Daniel Hausermann, Paul Bennetto, et al.

    Background/Objectives: The PEER beamline at the ANSTO Australian Synchrotron has been developed to enable VHEE FLASH radiotherapy studies, both dosimetric and biological. Featuring a 100 MeV electron linac, it delivers single or multi-pulse irradiations consisting of 100 ps bunches with a 2 ns spacing, resulting in average dose-rates and instantaneous dose-rates as high as 108 Gy/s and 109 Gy/s, respectively. Much work has been conducted to realise a stable accelerator facility, complete with the tooling and diagnostics required to undertake such studies. However, to truly confirm its suitability required a successful biological benchmarking. Methods: Three cell lines were irradiated utilising real-time dosimetry to compare linear quadratic cell survival curves with other facilities. Also, mouse cadavers were transported and irradiated, mimicking live animals, to assess the feasibility and logistics of small animal experiments. Results: By comparing the trends of the linear quadratic model, evident in the α and β parameters, the PEER cell survival results were shown to be in agreement with VHEE results from the ARES beamline at DESY, Hamburg, Germany. Evident in the survival trends, VHEE produced more cell sparing in all cell lines compared to 2 Gy/s X-rays delivered on the IMBL, another beamline at the Australian Synchrotron. The results of the mouse cadaver irradiations showed that PEER can safely and efficiently irradiate small animals. Conclusions: The PEER beamline is shown to possess suitable capabilities, including real-time dosimetry, repeatable alignment, and linac diagnostics, rendering it suitable for future in vivo VHEE UHDR FLASH radiotherapy investigations.


  • Open Access

    Amplifying image quality gain in x-ray phase contrast imaging of mastectomy samples with deep learning denoising

    by Ashkan Pakzad, Robert Turnbull, Simon J Mutch, Thomas A Leatham, Darren Lockie, Jane Fox, Beena Kumar, Daniel Hausermann, Christopher J Hall, Anton Maksimenko, et al.

    Objective: Phase-contrast computed tomography (PCT) of the breast has previously been shown to produce higher-quality images at lower radiation doses without the need for breast compression. The present study is aimed at further reduction of the radiation dose in PCT, while preserving or further increasing the image quality, by applying supervised deep learning denoising of reconstructed PCT images. This work was carried out in preparation for live patient PCT breast cancer imaging, initially at specialised synchrotron facilities. Approach: PCT scans of 34 fresh full mastectomy samples were acquired using propagation-based phase-contrast imaging with 32 keV monochromatic parallel X-rays at mean glandular doses of 4 mGy and 24 mGy. All scans were reconstructed using Filtered Back Projection algorithm with Paganin’s phase retrieval. A supervised U-Net-based deep learning denoising model was trained on 28 pairs of 4 mGy and 24 mGy scans and then applied to denoise the remaining 6 stacks of reconstructed 4 mGy images. Denoised PCT images were quantitatively evaluated using signal-to-noise ratio (SNR), spatial resolution, structural similarity index measure (SSIM) and peak-signal-to-noise ratio (PSNR). The images were also visually compared and systematically assessed by experienced medical imaging specialists and radiologists. Main Results: Deep learning denoising increased SNR by a factor of four while spatial resolution remained unchanged. SSIM and PSNR improved from 0.89 and 37 dB to 0.96 and 42 dB, respectively. Visual assessors significantly preferred the denoised images over the original 4 mGy images, and visual assessment indicated no increase in perceived artefacts in denoised images compared with the original 4 mGy images. Significance: Deep learning-based image denoising can further improve image quality in PCT without increasing radiation dose in imaging of mastectomies, supporting the feasibility of lower-dose PCT protocols or improved image quality for future clinical applications.


  • Open Access

    Establishing Linearity of the MOSkin Detector for Ultra-High Dose-per-Pulse, Very-High-Energy Electron Radiotherapy Using Dose-Rate-Corrected EBT-XD Film

    by James Cayley, Elette Engels, Tessa Charles, Paul Bennetto, Matthew Cameron, Joel Poder, Daniel Hausermann, Jason Paino, Duncan Butler, Dean Cutajar, et al.

    Very-high-energy electrons, coupled with ultra-high dose rates, are being explored for their potential use in radiotherapy to treat deep-seated tumours. The dose per pulse needed to achieve ultra-high dose rates far exceeds the limit of current medical linear accelerator capabilities. A high dose per pulse has been observed as the limiting factor for many existing dosimeters, resulting in saturation at doses far below what is required. The MOSkin, an existing clinical quality assurance dosimeter, has previously been demonstrated as dose rate independent but has not been subjected to a high dose per pulse. Within this study, the MOSkins dose-per-pulse response was tested for linearity, with a dose per pulse as high as 23 Gy within 200 ns at the ANSTO Australian Synchrotron’s Pulsed Energetic Electrons for Research facility. While using EBT-XD film as a reference dosimeter, a dose rate dependence of the EBT-XD was discovered. Once confirmed and a correction factor established, EBT-XD was used as an independent reference measurement. This work presents confirmation of the MOSkin suitability for ultra-high dose-rate environments with an electron energy of 100 MeV, and a theoretical discussion of its dose-rate and dose-per-pulse independence; the MOSkin is the only detector suitable for both clinical quality assurance, and ultra-high dose-rate measurements in its standard, unmodified form.


  • Open Access

    Treatment planning for in vivo multi-fraction, multi-port, multi-modal Synchrotron Radiotherapy

    by Micah J. Barnes, Matthew Cameron, Elette Engels, Mitzi Klein, Cristian Fernandez-Palomo, Jeffrey C. Crosbie, Liam Day, Paolo Pellicioli, Michael de Veer, Robin L. Anderson, et al.


  • Open Access

    Fast and Fractionated: Correlation of Dose Attenuation and the Response of Human Cancer Cells in a New Anthropomorphic Brain Phantom

    by Bernd Frerker, Elette Engels, Jason Paino, Vincent de Rover, John Paul Bustillo, Marie Wegner, Matthew Cameron, Stefan Fiedler, Daniel Häusermann, Guido Hildebrandt, et al.

    The results of radiotherapy in patients with primary malignant brain tumors are extremely dissatisfactory: the overall survival after a diagnosis of glioblastoma is typically less than three years. The development of spatially fractionated radiotherapy techniques could help to improve this bleak prognosis. In order to develop technical equipment and organ-specific therapy plans, dosimetry studies as well as radiobiology studies are conducted. Although perfect spheres are considered optimal phantoms by physicists, this does not reflect the wide variety of head sizes and shapes in our patient community. Depth from surface and X-ray dose absorption by tissue between dose entry point and target, two key parameters in medical physics planning, are largely determined by the shape and thickness of the skull bone. We have, therefore, designed and produced a biomimetic tool to correlate measured technical dose and biological response in human cancer cells: a brain phantom, produced from tissue-equivalent materials. In a first pilot study, utilizing our phantom to correlate technical dose measurements and metabolic response to radiation in human cancer cell lines, we demonstrate why an anthropomorphic phantom is preferable over a simple spheroid phantom.


  • Open Access

    Propagation-based phase-contrast imaging of the breast: image quality and the effect of X-ray energy and radiation dose

    by Indusaa Gunaseelan, Alaleh Amin Zadeh, Benedicta Arhatari, Anton Maksimenko, Christopher Hall, Daniel Hausermann, Beena Kumar, Jane Fox, Harry Quiney, Darren Lockie, et al.

    Objectives: Propagation-based phase-contrast computed tomography (PB-CT) is a new imaging technique that exploits refractive and absorption properties of X-rays to enhance soft tissue contrast and improve image quality. This study compares image quality of PB-CT and absorption-based CT (AB-CT) for breast imaging while exploring X-ray energy and radiation dose. Methods: Thirty-nine mastectomy samples were scanned at energy levels of 28-34keV using a flat panel detector at radiation dose levels of 4mGy and 2mGy. Image quality was assessed using signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), spatial resolution (res) and visibility (vis). Statistical analysis was performed to compare PB-CT images against their corresponding AB-CT images scanned at 32keV and 4mGy. Results: The PB-CT images at 4mGy, across nearly all energy levels, demonstrated superior image quality than AB-CT images at the same dose. At some energy levels, the 2mGy PB-CT images also showed better image quality in terms of CNR/Res and vis compared to the 4mGy AB-CT images. At both investigated doses, SNR and SNR/res were found to have a statistically significant difference across all energy levels. The difference in vis was statistically significant at some energy levels. Conclusion: This study demonstrates superior image quality of PB-CT over AB-CT, with X-ray energy playing a crucial role in determining image quality parameters. Advances in knowledge: Our findings reveal that standard dose PB-CT outperforms standard dose AB-CT across all image quality metrics. Additionally, we demonstrate that low dose PB-CT can produce superior images compared to standard dose AB-CT in terms of CNR/Res and vis.


  • Open Access

    A Novel Anthropomorphic Phantom Composed of Tissue-Equivalent Materials for Use in Experimental Radiotherapy: Design, Dosimetry and Biological Pilot Study

    by Thomas Breslin, Jason Paino, Marie Wegner, Elette Engels, Stefan Fiedler, Helen Forrester, Hannes Rennau, John Bustillo, Matthew Cameron, Daniel Häusermann, et al.

    The production of anthropomorphic phantoms generated from tissue-equivalent materials is challenging but offers an excellent copy of the typical environment encountered in typical patients. High-quality dosimetry measurements and the correlation of the measured dose with the biological effects elicited by it are a prerequisite in preparation of clinical trials with novel radiotherapy approaches. We designed and produced a partial upper arm phantom from tissue-equivalent materials for use in experimental high-dose-rate radiotherapy. The phantom was compared to original patient data using density values and Hounsfield units obtained from CT scans. Dose simulations were conducted for broad-beam irradiation and microbeam radiotherapy (MRT) and compared to values measured in a synchrotron radiation experiment. Finally, we validated the phantom in a pilot experiment with human primary melanoma cells.


  • Open Access

    The Spinal Cord as Organ of Risk: Assessment for Acute and Subacute Neurological Adverse Effects after Microbeam Radiotherapy in a Rodent Model

    by Felix Jaekel, Jason Paino, Elette Engels, Mitzi Klein, Micah Barnes, Daniel Häusermann, Christopher Hall, Gang Zheng, Hongxin Wang, Guido Hildebrandt, et al.

    Microbeam radiotherapy (MRT), a high dose rate radiotherapy technique using spatial dose fractionation at the micrometre range, has shown a high therapeutic efficacy in vivo in different tumour entities, including lung cancer. We have conducted a toxicity study for the spinal cord as organ of risk during irradiation of a target in the thoracic cavity. In young adult rats, the lower thoracic spinal cord was irradiated over a length of 2 cm with an array of quasi-parallel microbeams of 50 µm width, spaced at a centre-to-centre distance of 400 µm, with MRT peak doses up to 800 Gy. No acute or subacute adverse effects were observed within the first week after irradiation up to MRT peak doses of 400 Gy. No significant differences were seen between irradiated animals and non-irradiated controls in motor function and sensitivity, open field test and somatosensory evoked potentials (SSEP). After irradiation with MRT peak doses of 450–800 Gy, dose-dependent neurologic signs occurred. Provided that long-term studies do not reveal significant morbidity due to late toxicity, an MRT dose of 400 Gy can be considered safe for the spinal cord in the tested beam geometry and field size.